Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Apr 1, 2026 · Filed Apr 3, 2026
A board member of Docusign sold $144K of Docusign shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$144,450
Shares × reported transaction price
15 days after results of Mar 17, 2026, 64 days before results of Jun 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.5% | +4.1% | −9.6% |
| 30 days | −3.2% | +11.4% | −14.5% |
| 90 days | −2.4% | +14.0% | −16.4% |
| 180 days | +45.7% | +17.6% | +28.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$124K of Docusign
Scheduled in advance